Compare Genuine Parts Company (GPC) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genuine Parts Company vs ResMed Inc. — how do they compare? Genuine Parts Company trades at $135.22 (market cap $18.62B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: ResMed Inc. is the larger of the two by market cap, and Genuine Parts Company pays the higher dividend (3.15%). Which is the better fit depends on your goals.
| GPC | RMD | |
|---|---|---|
Market Cap | $18.62B | $32.61B |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $293.73 |
52-Week Low | $92.47 | $182.82 |
Enterprise Value | $24.72B | $31.97B |
Dividend Yield | 3.15% | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
